Impact of ART on the fertility of HIV-positive women in sub-Saharan Africa

Tropical Medicine and International Health

Volumn 21, Issue 9, 2016, Pages 1071-1085

  Yeatman, Sara ^a   Eaton, Jeffrey W ^b   Beckles, Zosia ^c   Benton, Lorna ^d   Gregson, Simon ^b,e   Zaba, Basia ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

antiretroviral therapy; births; fertility; HIV; pregnancy; sub Saharan Africa; systematic review

Indexed keywords

BIRTH DATE; COHORT ANALYSIS; DATA ASSIMILATION; DEMOGRAPHIC SURVEY; DISEASE TRANSMISSION; DISEASE TREATMENT; EPIDEMIC; FERTILITY; WORLD WIDE WEB;

AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; COMPARATIVE STUDY; FERTILITY; FUTUROLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVE BIRTH; PREGNANCY; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREND STUDY;

SUB-SAHARAN AFRICA;

EID: 84985896447     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12747     Document Type: Review

References (33)

1. Gregson S, Dharmayat K, Pereboom M et al. Do HIV prevalence trends in antenatal clinic surveillance represent trends in the general population in the antiretroviral therapy era? The case of Manicaland, East Zimbabwe. AIDS 2015: 29: 1845–1853.
2. Eaton JW, Rehle TM, Jooste S et al. Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS 2014: 28: S507–S514.
3. Zaba B, Gregson S. Measuring the impact of HIV on fertility in Africa. AIDS 1998: 12: S41–S50.
4. Chen W-J, Walker N. Fertility of HIV-infected women: insights from Demographic and Health Surveys. Sexual Trans Infect 2010: 86 (Suppl 2): ii22–ii27.
5. Lewis JJC, Ronsmans C, Ezeh A, Gregson S. The population impact of HIV on fertility in sub-Saharan Africa. AIDS 2004: 18: S35–S43.
6. Ross A, Van der Paal L, Lubega R, Mayanja BN, Shafer LA, Whitworth J. HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS 2004: 18: 799–804.
7. Desgrées du Loû A, Msellati P, Yao A et al. Impaired fertility in HIV-1-infected pregnant women: a clinic-based survey in Abidjan, Côte d, Ivoire, 1997. AIDS 1999: 13: 517–521.
8. Nguyen RHN, Gange SJ, Wabwire-Mangen F et al. Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda. Int J STD AIDS 2006: 17: 842–846.
9. Kaida A, Andia I, Maier M et al. The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep 2006: 3: 187–194.
10. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for Reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009: 6: 2–28.
11. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med 2010: 7: e1000229.
12. Burgos-Soto J, Balestre E, Minga A et al. Incidence of pregnancy after antiretroviral therapy initiation and associated factors in 8 West African Countries. J Acquir Immune Defic Syndr 2014: 67: e45–e54.
13. Marston M, Nakiyingi-Miiro J, Hosegood V, Lutalo T, Mtenga B, Zaba B. Measuring the Impact of Antiretroviral Therapy Roll-Out on Population Level Fertility in Three African Countries. PLoS ONE 2016: 11: e0151877.
14. Elul B, Wools-Kaloustian KK, Wu Y et al. Untangling the relationship between antiretroviral therapy use and incident pregnancy: a marginal structural model analysis using data from 47,313 HIV-positive women in East Africa. J Acquir Immune Defic Syndr 2016: 72: 324–332.
15. Lancaster KE, Kwok C, Rinaldi A et al. Incident pregnancy and pregnancy outcomes among HIV-infected women in Uganda and Zimbabwe. Int J Gynecol Obstet 2015: 131: 255–259.
16. UNAIDS. HIV prevalence among adults (15–49). (Available from: http://aidsinfo.unaids.org) [16 Dec 2015].
17. United Nations Population Division. World Population Prospects: The 2015 Revision. (Available from: http://esa.un.org/unpd/wpp/DataQuery/) [16 Dec 2015].
18. Souza E, Moultrie TA. Estimating the effect of HIV/AIDS on fertility among Malawian women using demographic and health survey data. Afr J AIDS Res 2015: 14: 315–321.
19. Maier M, Andia I, Emenyonu N et al. Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda. AIDS Behav 2009: 13(Suppl 1): 28–37.
20. Westreich D, Evans D, Firnhaber C, Majuba P, Maskew M. Prevalent pregnancy, biological sex, and virologic response to antiretroviral therapy. J Acquir Immune Defic Syndr 2012: 60: 489–494.
21. Tweya H, Feldacker C, Breeze E et al. Incidence of pregnancy among women accessing antiretroviral therapy in urban Malawi: a retrospective cohort study. AIDS Behav 2013: 17: 471–478.
22. Homsy J, Bunnell R, Moore D et al. Reproductive Intentions and Outcomes among Women on Antiretroviral Therapy in Rural Uganda: a Prospective Cohort Study. PLoS ONE 2009: 4: e4149.
23. Makumbi FE, Nakigozi G, Reynolds SJ et al. Associations between HIV antiretroviral therapy and the prevalence and incidence of pregnancy in Rakai, Uganda. AIDS Res Treat 2011; 2011: 1–10.
24. Patel RC, Onono M, Gandhi M et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Lancet HIV 2015: 2: e474–e482.
25. Guthrie BL, Choi RY, Liu AY et al. Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr (1999) 2011: 58: e87.
26. Kabami J, Turyakira E, Biraro S, Bajunirwe F. Increasing incidence of pregnancy among women receiving HIV care and treatment at a large urban facility in western Uganda. Reprod Health 2014: 11: 81.
27. Asiimwe-Kateera B, Veldhuijzen N, Balinda JP et al. Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months. AIDS Res Treat 2015: 2015: 740212.
28. Kaida A, Matthews LT, Kanters S et al. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS ONE 2013: 8: e63411.
29. Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V. High pregnancy intentions and missed opportunities for patient–provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy. AIDS Behav 2012: 16: 69–78.
30. World Health Organization. Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach (2nd edn), World Health Organization: Geneva, Switzerland, 2016.
31. ICAP. The Population-based HIV Impact Assessment Surveys, Columbia University. (Available from: http://icap.columbia.edu/global-initatives/the-phia-project/) [29 May 2016].
32. Stover J, Johnson P, Hallett T, Marston M, Becquet R, Timaeus I. The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect. 2010: 86 (Suppl 2): ii16–ii21.
33. Stover J, McKinnon R, Winfrey B. Spectrum: a model platform for linking maternal and child survival interventions with AIDS, family planning and demographic projections. Int J Epidemiol 2010: 39 (Suppl. 1): i7–i10.